Table 1.
Comparison of cardiovascular risk factors in the COVID-19 vs. control group
| Cardiovascular Risk Factors | COVID-19 Group |
Control Group |
P Value |
|---|---|---|---|
| N | 101 | 101 | |
| History of cardiovascular disease, n (%)* | |||
| Myocardial infarction | 4 (4) | 3 (3) | 0.72 |
| Heart failure | 2 (2) | 1 (1) | 0.62 |
| Stroke | 2 (2) | 3 (3) | >0.99 |
| Thrombosis | 2 (2) | 2 (2) | >0.99 |
| Hypertension | 17 (18) | 18 (18) | >0.99 |
| Hypercholesterolemia | 14 (15) | 13 (13) | 0.84 |
| Diabetes mellitus | 4 (4) | 4 (4) | >0.99 |
| Resuscitation | 1 (1) | 1 (1) | >0.99 |
| Smoking, n (%)** | 0.45 | ||
| Current | 6 (6) | 3 (3) | |
| Former | 32 (33) | 38 (39) | |
| Never | 58 (60) | 57 (58) | |
| Cholesterol, mmol/L | |||
| Total | 5.2 [4.8–5.9] | 5.1 [4.6–5.9] | 0.31 |
| HDL | 1.6 [1.3–1.8] | 1.6 [1.2–1.8] | 0.28 |
| LDL | 3.1 [2.6–3.6] | 3.0 [2.5–3.7] | 0.65 |
| Triglycerides, mmol/L | 1.1 [0.8–1.3] | 1.0 [0.8–1.5] | 0.96 |
| Glucose, mmol/L | 5.0 [4.8–5.3] | 4.9 [4.7–5.2] | 0.36 |
| Insulin, µIU/mL | 4.1 [2.0–7.1] | 3.8 [2.0–5.6] | 0.24 |
| Creatinine, µmol/L | 80 (SD 13) | 81 (SD 14) | 0.53 |
Values are n (%), medians [Q1–Q3], or means (SD); N, number of patients. *Data were missing for this factor and based on N = 96 (COVID-19 group) and N = 99 (control group). **Data were missing for this factor and based on N = 96 (COVID-19 group) and N = 98 (control group). Differences between groups were assessed with a Fisher’s exact test, Mann–Whitney U test or independent sample t test. COVID-19, coronavirus disease 2019; HDL, high-density lipoprotein; LDL, low-density lipoprotein.